New hope for kids with progeria: experimental drug combo enters mid-stage trial
Disease control
Ongoing
This study tests an experimental drug called progerinin, given together with the standard medicine lonafarnib, in children with Hutchinson-Gilford progeria syndrome (a rare disease that causes rapid aging). The goal is to find the best dose and check if the combination is safe an…
Phase: PHASE2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:20 UTC